Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease - A target for neuroprotective treatment strategies?

Journal of Neural Transmission, Supplement

Volumn , Issue 62, 2002, Pages 303-307

  Munch G ^a   Deuther Conrad, W ^a   Gasic Milenkovic, J ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; INDOMETACIN; TENILSETAM; THIOCTIC ACID; NEUROPROTECTIVE AGENT;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; CELL DEATH; CONFERENCE PAPER; CROSS LINKING; GLIA CELL; HUMAN; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; OXIDATIVE STRESS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; TARGET CELL; AGED; DRUG DESIGN; METABOLISM; REVIEW;

AGED; ALZHEIMER DISEASE; DRUG DESIGN; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS;

EID: 0036051027     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6139-5_28     Document Type: Conference Paper

References (14)

1. Bruce-Keller AJ, Li YJ, Lovell MA, Kraemer PJ, Gary DS, Brown RR, Markesbery WR, Mattson MP (1998) 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol 57: 257-267
2. Gsell W, Conrad R, Hickethier M, Sofic E, Frölich L, Wichart I, Jellinger K, Moll G, Ransmayr G, Beckmann H, Riederer P (1995) Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem 64: 1216-1223
3. Hager K, Marahrens A, Kenklies M, Riederer P, Münch G (2001) Alpha-lipoic acid as a new treatment option for Alzheimer type dementia. Arch Gerontol Geriatr 32: 275-282
4. Ihl R, Perisic I, Maurer K, Dierks T (1989) Effect of 3 months treatment with tenilsetam in patients suffering from dementia of Alzheimer type (DAT). J Neural Transm [P-D Sect] 1: 84-85
5. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT (1997) App(SW) transgenic mice develop age-related A-beta deposits and neuropil abnormalities, but no neuronal loss in CA 1. J Neuropathol Exp Neurol 56: 965-973
6. Loske C, Gerdemann A, Schepl W, Wycislo M, Schinzel R, Palm D, Riederer P, Münch G (2000) Transition metal mediated glycoxidation accelerates crosslinking of β-amyloid peptide. Eur J Biochem 267: 4171-4178
7. Münch G, Taneli Y, Schraven E, Schindler U, Schinzel R, Palm D, Riederer P (1994) The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm [P-D Sect] 8: 193-208
8. Münch G, Mayer S, Michaelis J, Hipkiss AR, Riederer P, Müller R, Neumann A, Schinzel R, Cunningham AM (1997) Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Acta 1360: 17-29
9. Neumann A, Schinzel R, Palm D, Riederer P, Münch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappa B activation and cytokine expression. FEBS Lett 453: 283-287
10. Retz W, Gsell W, Münch G, Rösler M, Riederer P (1998) Free radicals in Alzheimer's disease. J Neural Transm [Suppl 54]: 221-236
11. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, et al (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43: 1609-1611
12. Schweers O, Mandelkow EM, Biernat J, Mandelkow E (1995) Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci USA 92: 8463-8467
13. Smith MA, Sayre LM, Monnier VM, Perry G (1996) Oxidative posttranslational modifications in Alzheimer disease - a possible pathogenic role in the formation of senile plaques and neurofibrillary tangles. Mol Chem Neuropathol 28: 41-48
14. Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer-disease - DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. Neuropathol Exp Neurol 57: 456-464